Eventide Asset Management, LLC Bicycle Therapeutics PLC Transaction History

Eventide Asset Management, LLC

  • $6.2 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$12.95 - $46.99 $5.31 Million - $19.3 Million
-409,671 Reduced 32.42%
853,800 $14.3 Million
Q4 2021

Feb 14, 2022
BUY
$41.7 - $61.14 $4.17 Million - $6.11 Million
100,000 Added 8.59%
1,263,471 $76.9 Million
Q2 2021

Aug 16, 2021
BUY
$27.0 - $32.28 $20.3 Million - $24.3 Million
751,633 Added 182.51%
1,163,471 $35.3 Million
Q1 2021

May 14, 2021
BUY
$19.12 - $30.25 $7.87 Million - $12.5 Million
411,838 New
411,838 $12.3 Million

Others Institutions Holding BCYC

# of Institutions
99
Shares Held
30.6M
Call Options Held
85.5K
Put Options Held
11.6K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $600M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email